Bse

The index was launched in July 2017 and currently has high allocation to defensive sectors such as consumer goods (35.48 per cent), pharma (25.84 per cent) and Information technology (10.71 per cent). The portfolio’s price to earnings ratio stands at 29.11, while the price to book ratio is 5.03. The valuations are on the higher side. … [Read more...] about ICICI Pru Alpha Low Vol 30 ETF NFO: Should you invest?

The company has received approval from the US Food and Drug Administration (USFDA) for its abbreviated new drug application (ANDA)Vardenafil Hydrochloride tablets in the strengths of 2.5 mg, 5 mg, 10 mg and 20 mg, Alembic Pharmaceuticals said in a BSE filing. … [Read more...] about Alembic Pharmaceuticals gets USFDA nod for erectile dysfunction drug

Link PharmachemStandalone Quarterly Resultsin Rs. Cr.Jun'20Mar'20Jun'19Net Sales/Income from operations5.105.815.58Other Operating Income------Total Income From Operations5.105.815.58EXPENDITUREConsumption of Raw Materials1.281.051.54Purchase of Traded Goods------Increase/Decrease in Stocks-0.100.520.67Power & Fuel------Employees Cost1.131.101.20Depreciation0.230.260.22Excise Duty------Admin. And Selling Expenses------R & D Expenses------Provisions And Contingencies------Exp. Capitalised------Other Expenses2.012.231.49P/L Before Other Inc. , Int., Excpt. Items & Tax0.550.640.45Other Income0.000.10--P/L Before Int., Excpt. Items & Tax0.550.730.45Interest0.100.110.10P/L Before Exceptional Items & Tax0.440.620.36Exceptional Items------P/L Before Tax0.440.620.36Tax0.120.330.10P/L After Tax from Ordinary Activities0.320.290.25Prior Year Adjustments------Extra Ordinary Items------Net Profit/(Loss) For the Period0.320.290.25Equity Share Capital4.444.444.44Reserves … [Read more...] about Link Pharmachem Standalone June 2020 Net Sales at Rs 5.10 crore, down 8.53% Y-o-Y

AtishayStandalone Quarterly Resultsin Rs. Cr.Jun'20Mar'20Jun'19Net Sales/Income from operations6.396.795.12Other Operating Income------Total Income From Operations6.396.795.12EXPENDITUREConsumption of Raw Materials4.044.562.65Purchase of Traded Goods0.030.03--Increase/Decrease in Stocks-0.020.030.19Power & Fuel------Employees Cost0.701.121.25Depreciation0.410.530.31Excise Duty------Admin. And Selling Expenses------R & D Expenses------Provisions And Contingencies------Exp. Capitalised------Other Expenses0.320.840.48P/L Before Other Inc. , Int., Excpt. Items & Tax0.91-0.310.24Other Income0.070.530.35P/L Before Int., Excpt. Items & Tax0.980.220.59Interest0.140.090.07P/L Before Exceptional Items & Tax0.850.130.52Exceptional Items------P/L Before Tax0.850.130.52Tax0.27-0.320.11P/L After Tax from Ordinary Activities0.580.450.41Prior Year Adjustments------Extra Ordinary Items------Net Profit/(Loss) For the Period0.580.450.41Equity Share Capital10.9810.9810.98Reserves … [Read more...] about Atishay Standalone June 2020 Net Sales at Rs 6.39 crore, up 24.83% Y-o-Y

Prem Somani Financial ServicesStandalone Quarterly Resultsin Rs. Cr.Jun'20Mar'20Jun'19Net Sales/Income from operations0.010.010.01Other Operating Income------Total Income From Operations0.010.010.01EXPENDITUREConsumption of Raw Materials------Purchase of Traded Goods------Increase/Decrease in Stocks------Power & Fuel------Employees Cost0.010.010.00Depreciation0.000.000.00Excise Duty------Admin. And Selling Expenses------R & D Expenses------Provisions And Contingencies------Exp. Capitalised------Other Expenses0.040.210.05P/L Before Other Inc. , Int., Excpt. Items & Tax-0.04-0.21-0.05Other Income-0.03-0.010.01P/L Before Int., Excpt. Items & Tax-0.06-0.23-0.04Interest------P/L Before Exceptional Items & Tax-0.06-0.23-0.04Exceptional Items------P/L Before Tax-0.06-0.23-0.04Tax------P/L After Tax from Ordinary Activities-0.06-0.23-0.04Prior Year Adjustments------Extra Ordinary Items------Net Profit/(Loss) For the Period-0.06-0.23-0.04Equity Share … [Read more...] about Prem Somani Standalone June 2020 Net Sales at Rs 0.01 crore, up 103.77% Y-o-Y